The movement to make New York City the next big biotech hub is getting a boost through the official opening of a new JLABS incubator in trendy SoHo. This ribbon-cutting makes J&J’s 10th JLABS center, with others already helping hundreds of biotechs get started from Boston/Cambridge through Toronto, the Bay Area and Shanghai.
The pharma giant is technologically promiscuous — with interests in drugs, devices and consumer products — and has worked under CSO Paul Stoffels to create a global network of BD teams and start-up facilities aimed at working with fledgling companies out to do something new and unique. And they’ve been known to follow up with venture investments and partnerships if they see something with the kind of potential they’re in search of.
This new JLABS opens with 26 upstart residents working on everything from AI to cartilage implants and CNS diseases. And there’s room for a few more. You can see the whole list here.
Read more in Endpoints News.